A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects
The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of Fuzuloparib Capsules in healthy subject.
Solid Tumor
DRUG: Fuzuloparib
Maximum Plasma Concentration (Cmax), day 1 to day 10|Area under the plasma concentration versus time curve from time 0 to last time of measurable concentration (AUC0-t), day 1 to day 10|Area under the plasma concentration versus time curve from time 0 to infinity (AUC0-âˆž ), day 1 to day 10
The incidence and severity of adverse events/serious adverse events, from ICF signing date to approximate day 23
The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of Fuzuloparib Capsules in healthy subject.